CRC Research Update — September 22, 2026
Today's colorectal cancer research highlights
liver-mets
A collection of 85 issues
Gut bacterium Eggerthella lenta linked to liver metastasis via vascular barrier disruption
Skip to content
The CRC Digest
◇ RESEARCH
Gut bacterium Eggerthella lenta linked to liver metastasis via vascular barrier disruption
Multi-omics analysis of two cohorts comprising 20 healthy controls, 82 non-metastatic CRC patients, and 65 patients with liver or lung metastases found that those with CRC liver metastasis had impaired gut
CRC Research Update — September 19, 2026
Today's colorectal cancer research highlights
Pathological complete response to pembrolizumab in dMMR CRC despite radiological residual disease
Skip to content
The CRC Digest
Pathological complete response to pembrolizumab in dMMR CRC despite radiological residual disease
A case report describes a 70-year-old man with dMMR sigmoid colon cancer and liver metastases who achieved pathological complete response in both primary and metastatic lesions after preoperative pembrolizumab, despite imaging suggesting
CRC Research Update — September 16, 2026
Today's colorectal cancer research highlights
CRC Research Update — September 14, 2026
Today's colorectal cancer research highlights
Pooled Analysis Examines Prognostic Value of KRAS Mutations and Liver Metastases
Skip to content
The CRC Digest
Pooled Analysis Examines Prognostic Value of KRAS Mutations and Liver Metastases
A pooled analysis of third-line placebo-controlled trials from the ARCAD CRC Database evaluated the prognostic impact of liver metastases and KRAS mutations in metastatic colorectal cancer patients. (Clinical Colorectal Cancer)
This content is
CRC Research Update — September 13, 2026
Today's colorectal cancer research highlights
CRC Research Update — September 12, 2026
Today's colorectal cancer research highlights
CRC Research Update — September 08, 2026
Today's colorectal cancer research highlights